Andorra Tech Monitor: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Andorra Tech Monitor.

Press releases published on May 11, 2026

17 minutes ago

Invivyd and Collaborators Author New Manuscript Evaluating Early Tolerability of COVID Monoclonal Antibody and Comparing Results to COVID Vaccination

Indeterminate GlobeNewswire

18 minutes ago

4basebio Launches Enzymatic ssDNA Platform

Indeterminate GlobeNewswire

18 minutes ago

Evolution Metals & Technologies Corp. Secures $100 Million Investment from Yorkville Advisors Global, LP

Indeterminate GlobeNewswire

18 minutes ago

Apogee Therapeutics Provides Pipeline Progress and Reports First Quarter 2026 Financial Results

Indeterminate GlobeNewswire

18 minutes ago

OutSolve CEO to Speak on State & Federal Employment Regulations at Gartner CHRO Executive Summit in Minnesota

Indeterminate GlobeNewswire

18 minutes ago

Fractyl Health Authorized to Initiate First-in-Human Trial of RJVA-001 in the Netherlands: First Gene Therapy Candidate to Enter Clinical Development for Type 2 Diabetes

Indeterminate GlobeNewswire

18 minutes ago

SailPoint Launches Agentic Fabric to Secure AI Identities Across the Enterprise

Indeterminate GlobeNewswire

18 minutes ago

Sagimet Biosciences to Present Mechanism of Action Data for its FASN Inhibitors at the Society for Investigative Dermatology in Chicago

Indeterminate GlobeNewswire

18 minutes ago

Actuate Therapeutics Announces FDA Clearance of IND for Oral Elraglusib and Strategic Initiatives to Advance the Elraglusib Development Program

Indeterminate GlobeNewswire

18 minutes ago

Alpha Tau Announces Groundbreaking Interim Results from its U.S. Alpha DaRT® Recurrent Glioblastoma Trial, with 100% Local Disease Control, 67% Complete Response Rate, and Favorable Safety Profile Observed - Conference Call Scheduled for 8:30am ET

Indeterminate GlobeNewswire

18 minutes ago

Dark Horse Consulting Group and KunTuo Announce Memorandum of Understanding Providing Cell and Gene Therapy Developers with an Accelerated Path to Clinical Development in China

Indeterminate GlobeNewswire

an hour ago

Cineplex Reports First Quarter 2026 Results

Indeterminate GlobeNewswire

an hour ago

Liquidia Corporation Reports First Quarter 2026 Financial Results

Indeterminate GlobeNewswire

an hour ago

Certara Reports First Quarter 2026 Financial Results

Indeterminate GlobeNewswire

2 hours ago

As Enterprise AI Outpaces Governance, Alation Closes the Gap with New AI Governance Offering

Indeterminate GlobeNewswire

3 hours ago

Alvotech Announces Completion of FDA Surveillance Inspection at Reykjavik Facility

Indeterminate GlobeNewswire

3 hours ago

Chinese AI inspection firm opens Silicon Valley HQ as US manufacturing reshores

Indeterminate GlobeNewswire

3 hours ago

ENA Respiratory Successfully Completes First Part of Phase II Study of INNA-051 Nasal Spray Designed to Protect Against Symptomatic Viral Respiratory Infections

Indeterminate GlobeNewswire

3 hours ago

Anaveon Announces Presentation of Positive ANV600 Clinical Data at ASCO 2026 and Actively Seeks Partners for its Legacy Oncology Portfolio

Indeterminate GlobeNewswire

4 hours ago

Positive Results from PulseSight’s Phase I Clinical Trial of PST-611 in Dry AMD/Geographic Atrophy Presented at ARVO 2026

Indeterminate GlobeNewswire